Literature DB >> 17239012

TROY and LINGO-1 expression in astrocytes and macrophages/microglia in multiple sclerosis lesions.

J Satoh1, H Tabunoki, T Yamamura, K Arima, H Konno.   

Abstract

Nogo constitutes a family of neurite outgrowth inhibitors contributing to a failure of axonal regeneration in the adult central nervous system (CNS). Nogo-A is expressed exclusively on oligodendrocytes where Nogo-66 segment binds to Nogo receptor (NgR) expressed on neuronal axons. NgR signalling requires a coreceptor p75(NTR) or TROY in combination with an adaptor LINGO-1. To characterize the cell types expressing the NgR complex in the human CNS, we studied demyelinating lesions of multiple sclerosis (MS) brains by immunohistochemistry. TROY and LINGO-1 were identified in subpopulations of reactive astrocytes, macrophages/microglia and neurones but not in oligodendrocytes. TROY was up-regulated, whereas LINGO-1 was reduced in MS brains by Western blot. These results suggest that the ternary complex of NgR/TROY/LINGO-1 expressed on astrocytes, macrophages/microglia and neurones, by interacting with Nogo-A on oligodendrocytes, might modulate glial-neuronal interactions in demyelinating lesions of MS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17239012     DOI: 10.1111/j.1365-2990.2006.00787.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  34 in total

1.  Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligodendrocyte precursor cells in multiple sclerosis.

Authors:  Jin Nakahara; Kohsuke Kanekura; Mikiro Nawa; Sadakazu Aiso; Norihiro Suzuki
Journal:  J Clin Invest       Date:  2008-12-22       Impact factor: 14.808

2.  Lingo-1 expression is increased in essential tremor cerebellum and is present in the basket cell pinceau.

Authors:  Sheng-Han Kuo; Guomei Tang; Elan D Louis; Karen Ma; Rachel Babji; Matthew Balatbat; Etty Cortes; Jean-Paul G Vonsattel; Ai Yamamoto; David Sulzer; Phyllis L Faust
Journal:  Acta Neuropathol       Date:  2013-03-31       Impact factor: 17.088

3.  The neurite growth inhibitory protein Nogo-A has diverse roles in adhesion and migration.

Authors:  Andre Schmandke; Alice C Mosberger; Antonio Schmandke; Zeliha Celen; Martin E Schwab
Journal:  Cell Adh Migr       Date:  2013-11-19       Impact factor: 3.405

4.  Inhibition of TROY promotes OPC differentiation and increases therapeutic efficacy of OPC graft for spinal cord injury.

Authors:  Liang Sun; Shengliang Liu; Qi Sun; Zhuying Li; Fengyan Xu; Chunmei Hou; Toshihide Harada; Ming Chu; Kun Xu; Xiaoling Feng; Yongshun Duan; Yafang Zhang; Shuliang Wu
Journal:  Stem Cells Dev       Date:  2014-06-16       Impact factor: 3.272

Review 5.  p75NTR and TROY: Uncharted Roles of Nogo Receptor Complex in Experimental Autoimmune Encephalomyelitis.

Authors:  Paschalis Theotokis; Nikolaos Grigoriadis
Journal:  Mol Neurobiol       Date:  2018-01-02       Impact factor: 5.590

Review 6.  Extracellular cues influencing oligodendrocyte differentiation and (re)myelination.

Authors:  Natalie A Wheeler; Babette Fuss
Journal:  Exp Neurol       Date:  2016-03-23       Impact factor: 5.330

7.  LINGO-1 receptor promotes neuronal apoptosis by inhibiting WNK3 kinase activity.

Authors:  Zhaohuan Zhang; Xiaohui Xu; Zhenghua Xiang; Zhongwang Yu; Jifeng Feng; Cheng He
Journal:  J Biol Chem       Date:  2013-03-12       Impact factor: 5.157

8.  Gene expression profiling of human neural progenitor cells following the serum-induced astrocyte differentiation.

Authors:  Shinya Obayashi; Hiroko Tabunoki; Seung U Kim; Jun-ichi Satoh
Journal:  Cell Mol Neurobiol       Date:  2009-01-07       Impact factor: 5.046

Review 9.  Promoting remyelination for the treatment of multiple sclerosis: opportunities and challenges.

Authors:  Yueting Zhang; Taylor B Guo; Hongtao Lu
Journal:  Neurosci Bull       Date:  2013-04-05       Impact factor: 5.203

Review 10.  Astrocytes in multiple sclerosis: a product of their environment.

Authors:  A Nair; T J Frederick; S D Miller
Journal:  Cell Mol Life Sci       Date:  2008-09       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.